These results demonstrate that PFK15 treatment results in increased frequency of CD4+ T cells expressing checkpoint molecules PD-1 and LAG-3 in vivo, suggesting that inhibition of glycolysis induces potential T cell exhaustion thereby contributing to delayed T1D onset. Here, CD4 is linked to type 1 diabetes mellitus.